Development of Downstream Processing to Minimize Beta-Glucan Impurities in GMP-manufactured Therapeutic Antibodies

Biotechnology Progress - United States
doi 10.1002/btpr.2359
Full Text
Abstract

Available in full text

Categories
Biotechnology
Date
Authors
Publisher

Wiley

Related search

Immunoglobulin Restores Immune Responses to BTH1677 in Patients With Low Levels of Antibodies to Beta-Glucan

Anticancer Research
MedicineCancer ResearchOncology
2020English

Introduction to Therapeutic Antibodies

Journal of Tumor Medicine & Prevention
2018English

Integrated Flow-Through Purification for Therapeutic Monoclonal Antibodies Processing

mAbs
AllergyImmunology
2018English

Development of Therapeutic Anti-Jagged1 Antibodies for Cancer Therapy

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

The Effect of Beta on the Downstream Development of Unstable, Chaotic Baroclinic Waves

Journal of Physical Oceanography
Oceanography
2019English

Downstream Processing and Bioseparation

ACS Symposium Series
ChemistryChemical Engineering
1990English

Neutropenia Due to Beta Lactamine Antibodies.

BMJ
1984English

Characterization of Sodium Hypochlorite Degradation of .BETA.-Glucan in Relation to Its Metabolism in Vivo.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1996English

The Road to Toxin-Targeted Therapeutic Antibodies

mBio
VirologyMicrobiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy